companies with glp 1 drugs GLP-1 drug boom set to disrupt food High cost of GLP-1 drugs

Use of GLP-1 receptor agonists by individuals with obesity in the United States surged by around 700% between 2019 and 2023

References West S, Scragg J, Aveyard P, et al

Access the complete GLP-1 Pipeline Update table for August 2025

Data availability The data that support the findings of this study are available on request from the corresponding author (Bing Tan)

However, key impurities, such as Aspartate isomerization to isoAsp or racemization (D-amino acid formation), have the same mass and cannot be distinguished by mass alone

Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P, American College of R (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee